FDA Issues Draft Guidelines for Cancer Clinical Trials in Accelerated Approval
- March 31, 2023
The Food and Drug Administration (FDA) is looking to revamp the clinical trial approach for the accelerated approval of oncology therapeutics with new draft guidance issued March 24.
ARTICLE TAGS
You must be logged in to access this content.